The efficacy and safety of subcutaneous injection of bortezomib combined with doxorubicin and dexamethasone for untreated multiple myeloma patients.
Phase of Trial: Phase II
Latest Information Update: 23 Apr 2012
At a glance
- Drugs Bortezomib (Primary) ; Dexamethasone; Doxorubicin
- Indications Multiple myeloma
- Focus Therapeutic Use
- 23 Apr 2012 New trial record